Clinical trial
Impact of Erythropoietin Treatment Versus Placebo on Quality-of-life in Patients…
NCT00364455 · Janssen-Ortho Inc., Canada, Industry · Completed
Key facts
| NCT number | NCT00364455 |
|---|---|
| Title | Impact of Erythropoietin Treatment Versus Placebo on Quality-of-life in Patients With Advanced Prostate Cancer. |
| Official title | Randomized Trial of Epoetin Alfa in Men With Hormone-refractory Prostate Cancer and Anemia. |
| Lead sponsor | Janssen-Ortho Inc., Canada, Industry |
| Collaborators | Ontario Clinical Oncology Group (OCOG) |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate, Carcinoma |
| Intervention type | Drug |
| Interventions | Epoetin alfa |
| Enrollment | 56 |
| Start date | Dec 1, 2002 |
| Completion | Mar 1, 2006 |
| First posted | Aug 15, 2006 |
| Last update posted | Apr 27, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: